A major provider of DNA sequencing systems and related consumables used in genomic research, clinical laboratories, and drug development. Its platforms and reagents enable large-scale analysis of genetic material, making the company a central supplier to biotechnology firms, academic institutions, a...
5 members of Congress have disclosed 10 trades in Illumina, Inc. (ILMN), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-05-13 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2016-02-23 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2015-05-04 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2015-04-06 | MICHAEL T. MCCAUL | buy | $50K – $100K |
| 2015-02-09 | K. Michael Conaway | buy | $1K – $15K |
| 2015-01-27 | Thomas MacArthur | sell | $1K – $15K |
| 2014-03-04 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2014-02-14 | JAMES B. RENACCI | sell | $1K – $15K |
| 2014-01-08 | KENNY MARCHANT | buy | $1K – $15K |
| 2013-12-19 | MICHAEL T. MCCAUL | sell | $1K – $15K |